These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32623928)

  • 1. Incidence, clinical presentation, and outcomes of
    Barreto JN; Thompson CA; Wieruszewski PM; Pawlenty AG; Mara KC; Potter AL; Tosh PK; Limper AH
    Leuk Lymphoma; 2020 Nov; 61(11):2622-2629. PubMed ID: 32623928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction-based diagnosis in patients receiving bendamustine.
    Rice ML; Barreto JN; Thompson CA; Mara KC; Tosh PK; Limper AH
    Cancer Med; 2021 Aug; 10(15):5120-5130. PubMed ID: 34155819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer.
    Caselli D; Petris MG; Rondelli R; Carraro F; Colombini A; Muggeo P; Ziino O; Melchionda F; Russo G; Pierani P; Soncini E; DeSantis R; Zanazzo G; Barone A; Cesaro S; Cellini M; Mura R; Milano GM; Meazza C; Cicalese MP; Tropia S; De Masi S; Castagnola E; Aricò M;
    J Pediatr; 2014 Feb; 164(2):389-92.e1. PubMed ID: 24252793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole.
    Kato H; Samukawa S; Takahashi H; Nakajima H
    J Infect Chemother; 2019 Nov; 25(11):920-924. PubMed ID: 31300379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
    Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
    Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia.
    Tyagi AK; Mirdha BR; Luthra K; Guleria R; Mohan A; Singh UB; Samantaray JC; Dar L; Iyer VK; Chaudhry R
    J Infect Dev Ctries; 2010 Nov; 4(11):761-6. PubMed ID: 21252456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of pneumocystis pneumonia utilizing PCR-based diagnosis in patients with B-cell lymphoma receiving rituximab-containing combination chemotherapy.
    Barreto JN; Ice LL; Thompson CA; Tosh PK; Osmon DR; Dierkhising RA; Plevak MF; Limper AH
    Am J Hematol; 2016 Nov; 91(11):1113-1117. PubMed ID: 27472910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel droplet digital polymerase chain reaction for diagnosis of Pneumocystis pneumonia (PCP)-a clinical performance study and survey of sulfamethoxazole-trimethoprim resistant mutations.
    Jitmuang A; Nititammaluk A; Boonsong T; Sarasombath PT; Sompradeekul S; Chayakulkeeree M
    J Infect; 2021 Dec; 83(6):701-708. PubMed ID: 34562541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumocystis jirovecii pneumonia in diffuse large B-cell Lymphoma treated with R-CHOP.
    Lee JY; Kang M; Suh KJ; Kim JW; Kim SH; Kim JW; Kim YJ; Song KH; Kim ES; Kim HB; Lee KW; Kim JH; Bang SM; Lee JS; Lee JO
    Mycoses; 2021 Jan; 64(1):60-65. PubMed ID: 32970331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis.
    Jiang X; Mei X; Feng D; Wang X
    PLoS One; 2015; 10(4):e0122171. PubMed ID: 25909634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis jirovecii pneumonia in patients with autoimmune disease on high-dose glucocorticoid.
    Chew LC; Maceda-Galang LM; Tan YK; Chakraborty B; Thumboo J
    J Clin Rheumatol; 2015 Mar; 21(2):72-5. PubMed ID: 25710857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of Pneumocystis jirovecii Infection and Colonization in Immunocompromised Patients with Pneumonia].
    Gülbudak H; Öztürk C; Kuyugöz S; Tezcan Ülger S
    Mikrobiyol Bul; 2020 Oct; 54(4):583-595. PubMed ID: 33107287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis.
    Andreasen PB; Rezahosseini O; Møller DL; Wareham NE; Thomsen MT; Houmami R; Knudsen AD; Knudsen J; Kurtzhals JAL; Rostved AA; Pedersen CR; Rasmussen A; Nielsen SD
    Immun Inflamm Dis; 2022 Jan; 10(1):93-100. PubMed ID: 34713963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disorders.
    Obeid KM; Aguilar J; Szpunar S; Sharma M; del Busto R; Al-Katib A; Johnson LB
    Clin Lymphoma Myeloma Leuk; 2012 Feb; 12(1):66-9. PubMed ID: 22000698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predisposing factors, clinical characteristics and outcome of Pneumonocystis jirovecii pneumonia in HIV-negative patients.
    Kofteridis DP; Valachis A; Velegraki M; Antoniou M; Christofaki M; Vrentzos GE; Andrianaki AM; Samonis G
    J Infect Chemother; 2014 Jul; 20(7):412-6. PubMed ID: 24767467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study.
    Awad WB; Asaad A; Al-Yasein N; Najjar R
    BMC Infect Dis; 2020 Jun; 20(1):400. PubMed ID: 32503449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of
    Dunbar A; Schauwvlieghe A; Algoe S; van Hellemond JJ; Reynders M; Vandecasteele S; Boelens J; Depuydt P; Rijnders B
    Front Cell Infect Microbiol; 2020; 10():224. PubMed ID: 32500040
    [No Abstract]   [Full Text] [Related]  

  • 18. Anidulafungin as an alternative treatment for Pneumocystis jirovecii pneumonia in patients who cannot tolerate trimethoprim/sulfamethoxazole.
    Chen PY; Yu CJ; Chien JY; Hsueh PR
    Int J Antimicrob Agents; 2020 Jan; 55(1):105820. PubMed ID: 31622654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
    Ponce CA; Chabé M; George C; Cárdenas A; Durán L; Guerrero J; Bustamante R; Matos O; Huang L; Miller RF; Vargas SL
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients.
    Wei KC; Sy C; Wu SY; Chuang TJ; Huang WC; Lai PC
    Sci Rep; 2018 May; 8(1):8321. PubMed ID: 29844519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.